Sort by
Refine Your Search
-
of emerging devices. The ultimate goal is to explore the landscape of emerging hardware-based artificial intelligence systems to better understand the role played by measurement and metrology in these complex
-
modeling is the parametrization of the force field. There are a large number of force fields in existence and significant efforts are spent on their development and improvement. However, to-date, development
-
5235 Andrew J. Slifka andrew.slifka@nist.gov 303.497.3744 Description As hydrogen-fueled technologies gain traction throughout the world, a better set of standards is needed to govern the building
-
NIST only participates in the February and August reviews. A Bose-Einstein condensate (BEC) of a dilute gas is a unique quantum system with many atoms occupying the same quantum state of both
-
daniel.sunday@nist.gov 301 975 4921 Description Conventional optical-based photolithography is reaching the limits of scaling for the patterning and fabrication of nanoscale devices. The semiconductor industry
-
. Metagenomics is able to evaluate the presence of different taxa or specific genes while transcriptomics is able to define levels of gene expression, but proteomics seeks to identify and measure the translated
-
, economics, and all branches of science. Current concerns include the development and analysis of algorithms for the solution of problems of estimation, simulation and control of complex systems, and their
-
edward.sisco@nist.gov 301 975 2093 Description This opportunity focuses on developing new methods, metrics, approaches, and techniques for the forensic analysis of seized drugs. Seized drug analysis is the most
-
structure-mechanical property relationships are needed to enable diverse applications of these materials. There is a need for quantitative measurement methods to study the interfacial properties of the filler
-
Bergonzo christina.bergonzo@nist.gov (240)314 6333 John P. Marino john.marino@nist.gov 240.314.6361 Description There has been a recent emergence of RNA biotherapeutics; that is, small RNAs used as drug